Wafra Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-44,098
Closed -$4.56M 72
2021
Q4
$4.56M Hold
44,098
0.14% 62
2021
Q3
$5.53M Buy
44,098
+3,602
+9% +$466K 0.2% 63
2021
Q2
$5.03M Buy
40,496
+4,404
+12% +$553K 0.19% 55
2021
Q1
$4.26M Buy
36,092
+23,693
+191% +$2.78M 0.18% 55
2020
Q4
$1.45M Hold
12,399
0.06% 60
2020
Q3
$1.29M Hold
12,399
0.07% 60
2020
Q2
$1.14M Buy
+12,399
New +$1.19M 0.07% 62
2020
Q1
Sell
-11,007
Closed -$1.25M 70
2019
Q4
$1.25M Buy
+11,007
New +$1.21M 0.08% 64
2017
Q2
Sell
-99,711
Closed -$8.03M 94
2017
Q1
$8.03M Buy
99,711
+84,128
+540% +$6.57M 0.41% 52
2016
Q4
$1.11M Buy
+15,583
New +$1.22M 0.06% 75

Other funds holding MDT

Wafra Inc's MDT Position: Q1 2022 in Review

Wafra Inc sold out of Medtronic (MDT) in Q1 2022, closing a stake of 44,098 shares — an estimated $4.56M sold.

Wafra Inc first reported a position in MDT in Q4 2016 and held it in 10 quarters. The position peaked at $8.03M in Q1 2017. 2,102 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Wafra Inc reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Wafra Inc sold 44,098 Medtronic shares in Q1 2022, an estimated $4.56M.
  • Wafra Inc first reported a position in Medtronic in Q4 2016 and held it in 10 quarters.
  • Wafra Inc's Medtronic position peaked at $8.03M in Q1 2017.
  • 2,102 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Wafra Inc's 13F filing for Q1 2022, filed 16 May 2022.